Novo Q3 report: Wegovy pill now in eight markets including the UK
Novo's own report says the Wegovy pill had launched in the US, UAE, UK and Germany by the end of Q3 and is now in eight markets. It also flags 21% weight loss for CagriSema at 68 weeks in REDEFINE 9 and a planned US CagriSema launch in early 2027, subject to approval.
Source: Novo Nordisk (GlobeNewswire) (4 Nov 2026).